Interferon-Lambda: A Potent Regulator of Intestinal Viral Infections

被引:58
|
作者
Lee, Sanghyun [1 ]
Baldridge, Megan T. [2 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA
[2] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA
来源
FRONTIERS IN IMMUNOLOGY | 2017年 / 8卷
基金
美国国家卫生研究院; 新加坡国家研究基金会;
关键词
interferon-lambda; enteric virus; innate immunity; transkingdom interactions; norovirus; rotavirus; commensal bacteria; MURINE NOROVIRUS INFECTION; ACTIVATED PROTEIN-KINASES; HEPATITIS-C VIRUS; JAK-STAT PATHWAY; CELL-LINE HT-29; IFN-LAMBDA; III INTERFERON; IN-VIVO; INNATE IMMUNITY; ROTAVIRUS INFECTION;
D O I
10.3389/fimmu.2017.00749
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interferon-lambda (IFN-lambda) is a recently described cytokine found to be of critical importance in innate immune regulation of intestinal viruses. Endogenous IFN-lambda. has potent antiviral effects and has been shown to control multiple intestinal viruses and may represent a factor that contributes to human variability in response to infection. Importantly, recombinant IFN-lambda has therapeutic potential against enteric viral infections, many of which lack other effective treatments. In this mini-review, we describe recent advances regarding IFN-lambda-mediated regulation of enteric viruses with important clinical relevance including rotavirus, reovirus, and norovirus. We also briefly discuss IFN-lambda interactions with other cytokines important in the intestine, and how IFN-lambda may play a role in regulation of intestinal viruses by the commensal microbiome. Finally, we indicate currently outstanding questions regarding IFN-lambda control of enteric infections that remain to be explored to enhance our understanding of this important immune molecule.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] INTERFERONS AND SYSTEMIC SCLEROSIS: CORRELATION BETWEEN INTERFERON GAMMA AND INTERFERON-LAMBDA 1 (IL-29)
    Dantas, A. T.
    Goncalves, S. M. C.
    Pereira, M. C.
    Almeida, A. R.
    Marques, C. D. L.
    Rego, M. J. B. D. M.
    Pitta, I. D. R.
    Duarte, A. L. B. P.
    Pitta, M. G. D. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 910 - 910
  • [32] The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections
    Lozhkov, Alexey A.
    Klotchenko, Sergey A.
    Ramsay, Edward S.
    Moshkoff, Herman D.
    Moshkoff, Dmitry A.
    Vasin, Andrey V.
    Salvato, Maria S.
    PATHOGENS, 2020, 9 (12): : 1 - 25
  • [33] SEDIMENTATION EQUILIBRIUM MEASUREMENTS OF RECOMBINANT DNA-DERIVED HUMAN INTERFERON-LAMBDA
    YPHANTIS, DA
    BIOPHYSICAL JOURNAL, 1986, 49 (02) : A499 - A499
  • [34] Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections
    Mordstein, Markus
    Neugebauer, Eva
    Ditt, Vanessa
    Jessen, Birthe
    Rieger, Toni
    Falcone, Valeria
    Sorgeloos, Frederic
    Ehl, Stephan
    Mayer, Daniel
    Kochs, Georg
    Schwemmle, Martin
    Guenther, Stephan
    Drosten, Christian
    Michiels, Thomas
    Staeheli, Peter
    JOURNAL OF VIROLOGY, 2010, 84 (11) : 5670 - 5677
  • [35] Interferon-lambda is produced by and induces autocrine expression of interferon-stimulated genes in human bronchial epithelial cells
    Dickensheets, Harold
    Sheikh, Faruk
    Shepard, Rachel
    Hillyer, Philippa
    Rabin, Ronald L.
    Donnelly, Raymond P.
    CYTOKINE, 2013, 63 (03) : 259 - 259
  • [36] Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C
    Susser, Simone
    Herrmann, Eva
    Lange, Christian
    Hamdi, Nabila
    Mueller, Tobias
    Berg, Thomas
    Perner, Dany
    Zeuzem, Stefan
    Sarrazin, Christoph
    PLOS ONE, 2014, 9 (11):
  • [37] INTESTINAL VIRAL INFECTIONS
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 160 (16): : 1438 - 1438
  • [38] Interferon-lambda (IFNL) germline variants and responsiveness to chemo- and radiotherapy in cancer patients
    Hafemann, Mia Mala
    Mihm, Sabine
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 150 - 150
  • [39] Chemoresistance in Hepatocellular Carcinoma is Modulated by Interleukin-29 (Interferon-Lambda 1) and Rapamycin
    Schwarz, Bettina
    Beigel, Florian
    Zhao, Yue
    Jauch, Karl W.
    Goeke, Burkhard
    Brand, Stephan
    Bruns, Christiane
    GASTROENTEROLOGY, 2012, 142 (05) : S706 - S706
  • [40] Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent
    Hillyer, Philippa
    Mane, Viraj P.
    Schramm, Lynnsie M.
    Puig, Montserrat
    Verthelyi, Daniela
    Chen, Aaron
    Zhao, Zeng
    Navarro, Maria B.
    Kirschman, Kevin D.
    Bykadi, Srikant
    Jubin, Ronald G.
    Rabin, Ronald L.
    IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (08): : 774 - 783